CICALA, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 2.553
EU - Europa 1.784
AS - Asia 950
SA - Sud America 261
Continente sconosciuto - Info sul continente non disponibili 89
AF - Africa 38
OC - Oceania 7
Totale 5.682
Nazione #
US - Stati Uniti d'America 2.459
RU - Federazione Russa 902
SG - Singapore 371
IT - Italia 255
CN - Cina 216
BR - Brasile 204
IE - Irlanda 133
HK - Hong Kong 109
SE - Svezia 105
DE - Germania 68
VN - Vietnam 66
IN - India 64
CA - Canada 49
PL - Polonia 49
GB - Regno Unito 43
FR - Francia 42
CH - Svizzera 39
EE - Estonia 38
FI - Finlandia 27
NL - Olanda 20
BD - Bangladesh 19
MX - Messico 17
IQ - Iraq 15
ID - Indonesia 13
EC - Ecuador 12
AT - Austria 11
AR - Argentina 10
ES - Italia 10
CL - Cile 9
CO - Colombia 9
TR - Turchia 9
VE - Venezuela 9
CI - Costa d'Avorio 8
JP - Giappone 8
BE - Belgio 7
ZA - Sudafrica 7
PK - Pakistan 6
TW - Taiwan 6
UA - Ucraina 6
AU - Australia 5
JM - Giamaica 5
LT - Lituania 5
MA - Marocco 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
CZ - Repubblica Ceca 4
PH - Filippine 4
UY - Uruguay 4
UZ - Uzbekistan 4
BG - Bulgaria 3
CY - Cipro 3
EG - Egitto 3
HN - Honduras 3
IL - Israele 3
KZ - Kazakistan 3
LB - Libano 3
MY - Malesia 3
NP - Nepal 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AL - Albania 2
BO - Bolivia 2
BS - Bahamas 2
BZ - Belize 2
DK - Danimarca 2
DZ - Algeria 2
GE - Georgia 2
JO - Giordania 2
KE - Kenya 2
LV - Lettonia 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PY - Paraguay 2
RS - Serbia 2
SC - Seychelles 2
SN - Senegal 2
AZ - Azerbaigian 1
BM - Bermuda 1
BN - Brunei Darussalam 1
CD - Congo 1
DO - Repubblica Dominicana 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
IS - Islanda 1
KR - Corea 1
LK - Sri Lanka 1
LY - Libia 1
MK - Macedonia 1
MQ - Martinica 1
NG - Nigeria 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
PW - Palau 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
Totale 5.588
Città #
Ashburn 367
Moscow 267
Singapore 234
Dallas 223
Chandler 141
Dublin 132
San Jose 120
Hong Kong 108
Los Angeles 73
Beijing 70
New York 57
Nyköping 55
Council Bluffs 51
The Dalles 49
Messina 47
Warsaw 44
Santa Clara 32
Munich 29
Rome 25
Ho Chi Minh City 23
Atlanta 21
Denver 21
Frankfurt am Main 21
Hyderabad 21
Orem 21
San Francisco 19
São Paulo 19
Turku 18
Princeton 17
Lauterbourg 16
Medford 14
Milan 14
Montreal 13
Redondo Beach 13
Seattle 13
Tianjin 13
Amsterdam 12
Buffalo 12
Dearborn 12
Boston 11
Brooklyn 11
Hanoi 11
North Bergen 11
Chennai 10
Guangzhou 10
Toronto 10
Vienna 10
Columbus 9
Paternò 9
Abidjan 8
Brescia 8
Chicago 8
Des Moines 8
Jacksonville 8
Mexico City 8
Mumbai 8
Phoenix 8
Stockholm 8
Tokyo 8
Baghdad 7
Brussels 7
Geneva 7
London 7
Pune 7
Zurich 7
Basel 6
Belo Horizonte 6
Bremen 6
Naples 6
Palermo 6
Quito 6
Bexley 5
Bologna 5
Changsha 5
Jakarta 5
Nuremberg 5
Rio de Janeiro 5
Santiago 5
Sydney 5
Wilmington 5
Brasília 4
Brno 4
Curitiba 4
Dong Ket 4
Helsinki 4
Houston 4
Istanbul 4
Lappeenranta 4
Memphis 4
Montevideo 4
Ottawa 4
Poplar 4
Salvador 4
San José 4
Vancouver 4
Berlin 3
Biên Hòa 3
Bogotá 3
Caracas 3
Charlotte 3
Totale 2.837
Nome #
Clinically Relevant Interactions between Atypical Antipsychotics and Anti-Infective Agents 480
Safety and Tolerability of Antipsychotic Drugs in Pediatric Patients: Data From a 1-Year Naturalistic Study 318
Neuropsychiatric Adverse Events with Monoclonal Antibodies Approved for Multiple Myeloma: An Analysis from the FDA Adverse Event Reporting System 269
Anti-obesity drug therapy in clinical practice: Evidence of a poor prescriptive attitude 243
Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database 242
A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children 237
Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study 233
A comprehensive review of swallowing difficulties and dysphagia associated with antipsychotics in adults. 232
Dual orexin receptor antagonists for the treatment of insomnia disorder: Real-world safety evidence analysis and comparison with established therapeutic options 221
Clinically relevant drug interactions between newer antidepressants and oral anticoagulants 210
Adverse reactions related to proton pump inhibitors in pediatric population: an analysis of spontaneous reporting data 201
Ototoxic adverse drug reactions: A disproportionality analysis using the Italian spontaneous reporting database 198
Chronic Kidney Disease Management in General Practice: A Focus on Inappropriate Drugs Prescriptions 194
Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database 189
Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project 188
Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database 172
Safety and tolerability of antipsychotic drugs in pediatric patients: data from an ongoing active pharmacovigilance study in Sicily 171
Pediatric adverse reactions to antiseizure medications – An analysis of data from the Italian spontaneous reporting system (2001–2019) 169
Biosimilars in Pediatric Inflammatory Bowel Diseases: A Systematic Review and Real Life-Based Evidence 163
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study 157
Spontaneous reporting of adverse reactions related to proton pump inhibitors 145
Cardiovascular Adverse Drug Reactions of Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies for Migraine Prevention: An Analysis from the European Spontaneous Adverse Event Reporting System 138
Safety of Inclisiran: A Disproportionality Analysis from the EudraVigilance Database 126
Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting System 116
Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System 112
Cardiovascular Safety Profile of BRAF and MEK Inhibitors in Melanoma: FAERS Data Through a Retrospective Disproportionality Analysis (2014–2023) 96
Renal Disorders with Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: An Analysis from the FDA Adverse Event Reporting System Database 84
Unveiling cardiovascular and respiratory toxicities with monoclonal antibodies in multiple myeloma: disproportionality analysis from the FDA Adverse Event Reporting System 83
Tolerability profile of paliperidone palmitate formulations: A pharmacovigilance analysis of the EUDRAVigilance database 72
Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data 65
Inflammation and depression: A study protocol to dissect pathogenetic mechanisms in the onset, comorbidity and treatment response 56
Two Years of Active Pharmacovigilance Surveillance and Therapeutic Reconciliation in Frail Populations: The MEAP 3.0 Study 51
Factors Associated with Parental Vaccine Hesitancy in Childhood Immunization: Insights from a Cross-Sectional Survey in Southern Italy 29
null 22
Totale 5.682
Categoria #
all - tutte 17.079
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.079


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022121 0 0 0 2 4 4 9 7 1 39 6 49
2022/2023414 29 56 16 40 23 43 3 30 160 3 9 2
2023/2024171 7 16 25 12 10 34 11 8 2 25 6 15
2024/2025900 16 17 11 69 25 43 24 218 155 107 104 111
2025/20262.566 163 136 227 171 222 420 295 340 320 152 44 76
2026/20271.360 124 487 372 377 0 0 0 0 0 0 0 0
Totale 5.682